Latest News about GBT
Recent news which mentions GBT
Global Blood Therapeutics's Return On Capital Employed Overview
September 15, 2022
Tickers
GBT
From Benzinga
Global Blood Therapeutics's Return On Capital Employed Overview
September 01, 2022
Tickers
GBT
From Benzinga
After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal
September 01, 2022
From Benzinga
3 Biopharmas on Buyout Watch
August 22, 2022
From Motley Fool
Tickers
GBT
From Best Stocks
Has Moderna Made a Bear Market Blunder?
August 17, 2022
From Motley Fool
Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US
August 09, 2022
From Benzinga
From MarketWatch
8 Analysts Have This to Say About Global Blood Therapeutics
August 09, 2022
Tickers
GBT
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022
August 09, 2022
From Benzinga
From Motley Fool
From Benzinga
TBLT, RDBX: The Top 5 Short Squeeze Stocks to Watch This Week
August 08, 2022
From InvestorPlace
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
From Benzinga
From Benzinga
Pfizer Scoops Up Sickle Disease Player For $5B
August 08, 2022
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 05, 2022
From Benzinga
Why Global Blood Therapeutics Stock Is Vaulting Higher Today
August 05, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 04, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.